PharmaShots | Incisive News in 3 Shots

Subscribe Now

Korean

Celltrion's Regdanvimab (CT-P59) Receives Korean MFDS Conditional Marketing Authorization for COVID-19

Celltrion's Regdanvimab (CT-P59) Receives Korean MFDS Conditional Marketing Authorization for COVID-19

February 8, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us